相关实验视频

Updated: Jul 8, 2026

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

可吸入的mRNA纳米粒子具有增强的雾化稳定性和肺微环境透

Mincheol Jang¹, Kyunghwan Yeom¹, Junhee Han¹

¹Department of Bio and Brain Engineering and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.

|August 22, 2024

概括

开发新的可电离性脂质体-mRNA脂质复合体 (iLPX) 增强了通过雾化将信使RNA (mRNA) 输送到肺部. 这一突破为治疗肺部疾病提供了一个有希望的策略,其稳定性和有效性得到了提高.

科学领域:

药物通过肺部输送.
纳米医学是一种纳米医学.
基因治疗是一种基因疗法.

背景情况:

将信使RNA (mRNA) 输送到肺部对于治疗肺部疾病至关重要.
传统的脂质纳米颗粒 (LNPs) 对于全身传递是有效的,但由于不稳定性和微环境不兼容性,它们在肺吸入方面存在困难.

研究的目的:

开发和优化基于脂质的纳米颗粒,通过雾化有效和安全地将mRNA输送到肺部.
克服传统LNP在肺部输送中的局限性.

主要方法:

开发一种可电离的脂质体-mRNA脂质复合体 (iLPX),具有增强的结构稳定性和无聚乙烯甘醇的组成.
对iLPX配方的多步选,以选择一个针对吸入优化的版本 (IH-iLPX).
在体内评估IH-iLPX的传染效率,肺部分布和雾化后的毒性.

主要成果:

与传统LNP相比,开发的IH-iLPX在雾化过程中表现出更高的稳定性.
在吸入后,IH-iLPX在肺部表现出卓越的mRNA转染效率.
没有观察到体内毒性,甚至在深肺区域的蛋白质表达,向上皮细胞.

结论:

新的IH-iLPX配方是吸入mRNA肺部治疗的有希望的平台.
这种方法解决了肺mRNA输送的关键挑战,提高了稳定性和有效性.
进一步开发IH-iLPX可能会导致治疗难治的肺部疾病的新疗法.

关键词:

吸入吸入的方法提供mRNA的交付.雾化雾化雾化肺部微环境中的微环境肺部表面活性剂的使用情况.

更多相关视频

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Inhaled Medications

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...